"...looking for clues to SEPR." ? Wonder what EB White invested in (besides children)?
Will SEPR turn into a super-generic pharma, as Ag suggests? IMHO their egos speak to more than that, though reality will have her way. (I've noticed.)
That comparison chart sure is impressive considering SEPR's earnings. I wonder what is in the future.
Neurodude, tell me. The thing about antidepressants seems to be that the most popular one is the newest one. I mean, they drive a hard bargain, offering psychic relief in exchange for sexual functioning and/or weight gain. And they are expensive! At least they don't ask for firstborn children. Seems to me Prozac has had an exceptional run for all the reasons we know, but the hope is always for the future, the next one, Celexa, Prozac II?, etc. It just gives me the feeling that, as usual, an investor who has parried all local underwear into SEPR shares in the hopes of being in on the next Microsoft must pay very careful attention, watch the chart, keep up with due dililgence, track down every rumor--dag, I'd better get back to work.
Be well.
j/fir |
